Ethnic, environmental, genetic, and familial risk factors for CLL
Earn CME credit for a related activity: https://www.naccme.com/oln
In this presentation from Lymphoma & Myeloma 2018, Dr. Susan Slager discusses the ethnic, enrivonmental, genetic, and familial risk factors for chronic lymphocytic leukemia (CLL).
© 2018 Imedex, an HMP Company
Видео Ethnic, environmental, genetic, and familial risk factors for CLL канала HMP Education
In this presentation from Lymphoma & Myeloma 2018, Dr. Susan Slager discusses the ethnic, enrivonmental, genetic, and familial risk factors for chronic lymphocytic leukemia (CLL).
© 2018 Imedex, an HMP Company
Видео Ethnic, environmental, genetic, and familial risk factors for CLL канала HMP Education
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
The Patient Centered IBD Medical Home: Will This be the Future of IBD Healthcare Delivery?
Key Insights: Updates in Colorectal Cancer
Do we have reliable biomarkers to guide use of immunotherapy agents?
Key Insights: Novel Targets for IBD Therapy - Is This the Final Frontier?
Segment 2: Risk Assessment in Prostate Cancer
Autoimmunity in CLL
Mechanisms of Angiogenesis Inhibitors in Metastatic Colorectal Cancer
Virtual Patient Case: Carcinoid Syndrome #1 - Initial Presentation
Challenges Facing Medical Oncology Practice in the Next Decade
New agents/strategies on the horizon in bile duct cancer
What Determines “Quality” for Endoscopy Reporting in IBD Patients?
Optimizing Lumbar Discectomy: Closing Holes in the Disc
Expert Perspectives: MPN and MDS
Molecular Alterations and New Drugs in Bile Duct Cancer
Testing for BRCA Germline Mutations in the Clinic and the Mechanism of Action of PARP Inhibitors
Update on dysplasia detection: Should you use chromoendoscopy?
Multiple Myeloma Update: Maintenance Therapy
Early Stage HER2+ Breast Cancer - Dr. Christy Russell
The Current Landscape of Biosimilars in IBD
Picking a Treatment Target: Is it as “Simple” as Mucosal Healing?
Optimizing Biological Therapies in the Modern Era